635 related articles for article (PubMed ID: 30394846)
1. Prevalence and Mechanisms of Carbapenem Resistance Among
Benmahmod AB; Said HS; Ibrahim RH
Microb Drug Resist; 2019 May; 25(4):480-488. PubMed ID: 30394846
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt.
Al-Agamy MH; Khalaf NG; Tawfick MM; Shibl AM; El Kholy A
Int J Infect Dis; 2014 May; 22():49-54. PubMed ID: 24607428
[TBL] [Abstract][Full Text] [Related]
3. Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23.
El Bannah AMS; Nawar NN; Hassan RMM; Salem STB
Microb Drug Resist; 2018 Apr; 24(3):269-277. PubMed ID: 28783427
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates from Egyptian patients.
Hassan RM; Salem ST; Hassan SIM; Hegab AS; Elkholy YS
PLoS One; 2021; 16(6):e0251508. PubMed ID: 34166384
[TBL] [Abstract][Full Text] [Related]
6. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan.
Hasan B; Perveen K; Olsen B; Zahra R
J Med Microbiol; 2014 Jan; 63(Pt 1):50-55. PubMed ID: 24085817
[TBL] [Abstract][Full Text] [Related]
7. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital.
Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA
J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594
[TBL] [Abstract][Full Text] [Related]
9. Dissemination of bla
Leungtongkam U; Thummeepak R; Wongprachan S; Thongsuk P; Kitti T; Ketwong K; Runcharoen C; Chantratita N; Sitthisak S
Microb Drug Resist; 2018; 24(1):55-62. PubMed ID: 28594634
[TBL] [Abstract][Full Text] [Related]
10. ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
Agoba EE; Govinden U; Peer AKC; Osei Sekyere J; Essack SY
Microb Drug Resist; 2018 Nov; 24(9):1289-1295. PubMed ID: 29653481
[TBL] [Abstract][Full Text] [Related]
11. Multidrug- and Extensively Drug-Resistant
Romanin P; Palermo RL; Cavalini JF; Fávaro LDS; De Paula-Petroli SB; Fernandes EV; Dos Anjos Szczerepa MM; Tognim MCB; Yamada-Ogatta SF; Carrara-Marroni FE; Yamauchi LM
Microb Drug Resist; 2019 Nov; 25(9):1365-1373. PubMed ID: 31361565
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem-resistant Acinetobacter baumannii: Current status of the problem in four Bulgarian university hospitals (2014-2016).
Strateva T; Sirakov I; Stoeva T; Stratev A; Dimov S; Savov E; Mitov I
J Glob Antimicrob Resist; 2019 Mar; 16():266-273. PubMed ID: 30412782
[TBL] [Abstract][Full Text] [Related]
13. Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt.
Said HS; Benmahmod AB; Ibrahim RH
World J Microbiol Biotechnol; 2018 Dec; 34(12):189. PubMed ID: 30511216
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genotypic characterization of carbapenem-resistant
Abouelfetouh A; Torky AS; Aboulmagd E
Antimicrob Resist Infect Control; 2019; 8():185. PubMed ID: 31832185
[TBL] [Abstract][Full Text] [Related]
15. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
[TBL] [Abstract][Full Text] [Related]
16. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
[TBL] [Abstract][Full Text] [Related]
17. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.
Zander E; Chmielarczyk A; Heczko P; Seifert H; Higgins PG
J Antimicrob Chemother; 2013 Feb; 68(2):308-11. PubMed ID: 23014718
[TBL] [Abstract][Full Text] [Related]
18. Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii in the Intensive Care Unit of Uruguay's University Hospital Identifies the First rmtC Gene in the Species.
Bado I; Papa-Ezdra R; Delgado-Blas JF; Gaudio M; Gutiérrez C; Cordeiro NF; García-Fulgueiras V; Araújo Pirez L; Seija V; Medina JC; Rieppi G; Gonzalez-Zorn B; Vignoli R
Microb Drug Resist; 2018 Sep; 24(7):1012-1019. PubMed ID: 29920143
[TBL] [Abstract][Full Text] [Related]
19. Emergence of Carbapenem-Hydrolyzing Oxacillinases in Acinetobacter baumannii in Children from Croatia.
Lukić-Grlić A; Kos M; Žižek M; Luxner J; Grisold A; Zarfel G; Bedenić B
Chemotherapy; 2019; 64(4):167-172. PubMed ID: 31707391
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam.
Tuan Anh N; Nga TVT; Tuan HM; Tuan NS; Y DM; Vinh Chau NV; Baker S; Duong HHT
J Med Microbiol; 2017 Jan; 66(1):46-53. PubMed ID: 28198682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
